This cluster is routine post-vesting selling by top executives, the dollar amounts are negligible for a $23B company. The simultaneous option exercises suggest a scheduled vesting event rather than a coordinated bearish signal. No actionable trading signal here; monitor the next 10-Q for any fundamental changes.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 5 $549.87entry
- T+1 · 5mo ago −0.94%α −1.17% · $544.69
- T+5 · 5mo ago −0.71%α −1.28% · $545.96
- T+20 · 4mo ago −0.48%α −2.34% · $547.25
- T+60 · 3mo ago −7.20%α −11.20% · $510.26
Price Chart
How similar events traded
Executive Summary
Three top executives at United Therapeutics (CEO, CFO, General Counsel) collectively sold $1.11M in open-market shares over a 5-day window, all following derivative exercises at deep in-the-money strike prices. The sales are consistent with routine post-vesting tax and diversification activity, the total represents ~0.005% of the $23.3B market cap, well below the materiality threshold for informational selling. The cluster is amplified by the cross-filing context (cluster-insider-trades + cluster-earnings-context), but the absolute dollar value is trivial for a company of this size.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 2,926 shares total across 3 days for ~$1.58M, all after exercising options at $146.03
- CFO James Edgemond sold 1,440 shares for ~$785K after exercising options at $117.76
- General Counsel Paul Mahon sold 200 shares for ~$108K after exercising options at $146.03
- Total open-market sales: $1.11M, representing ~0.005% of UTHR's $23.3B market cap
- All three insiders simultaneously exercised options, a pattern consistent with scheduled vesting/expiration, not coordinated bearish conviction
Financial Impact
Total insider sales of $1.11M are immaterial relative to $23.3B market cap (0.005%)
Risk Factors
- Insider selling at the C-suite level, even if routine, can weigh on sentiment if the stock is at all-time highs
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1780608665703 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers